Journey Medical Corp (DERM)
5.30
+0.10
(+1.92%)
USD |
NASDAQ |
Nov 22, 16:00
5.30
0.00 (0.00%)
After-Hours: 16:29
Journey Medical Debt to Equity Ratio: 1.811 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.811 |
| June 30, 2024 | 1.748 |
| March 31, 2024 | 1.134 |
| December 31, 2023 | 0.7185 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 1988.40 |
| March 31, 2023 | 3.049 |
| December 31, 2022 | 1.341 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.7566 |
| June 30, 2022 | 0.4251 |
| March 31, 2022 | 0.3566 |
| December 31, 2021 | 0.0193 |
| September 30, 2021 | -1.279 |
| June 30, 2021 | -6.622 |
| March 31, 2021 | |
| December 31, 2020 | 0.5072 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.622
Minimum
Jun 2021
1988.40
Maximum
Jun 2023
132.82
Average
0.7185
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| Fortress Biotech Inc | 2.539 |
| Heron Therapeutics Inc | -4.361 |
| Eton Pharmaceuticals Inc | 0.2581 |
| Elutia Inc | -0.5627 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 64.04M |
| Total Liabilities (Quarterly) | 53.12M |
| Shareholders Equity (Quarterly) | 10.93M |
| Current Ratio | 1.385 |
| Net Debt Paydown Yield | -1.68% |